Inhibition of monoamine oxidase B in the brains of smokers

Nature

Volumn 379, Issue 6567, 1996, Pages 733-736

  Fowler, J S ^a   Volkow, N D ^a,b   Wang, G J ^a   Pappas, N ^a   Logan, J ^a   MacGregor, R ^a   Alexoff, D ^a   Shea, C ^a   Schlyer, D ^a   Wolf, A P ^a   Warner, D ^a   Zezulkova, I ^b   Cilento, R ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; HYDROGEN PEROXIDE; NICOTINE; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE;

ADDICTION; ADULT; ARTICLE; BEHAVIOR; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINE METABOLISM; ENZYME INHIBITION; FEMALE; HUMAN; LOCOMOTION; MALE; MENTAL DISEASE; MOTIVATION; NEUROPHARMACOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REINFORCEMENT; RISK;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; DOPAMINE; FEMALE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NICOTINE; SELEGILINE; SMOKING; TOMOGRAPHY, EMISSION-COMPUTED;

GYMNOMYZA SAMOENSIS; NICOTIANA TABACUM;

EID: 13344293709     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/379733a0     Document Type: Article

References (31)

1. Henningfield, J. E., Schuh, L. M. & Jarvik, M. E. in Psychopharmacology, the Fourth Generation of Progress (eds Bloom, F W. & Kupfer, D J.) Ch. 147, 1715-1729 (Raven, New York 1995).
2. Hughes, J. R., Hatsukama, D. K , Mitcrtell, J. E. & Dahlgren, L. A. Am. J Psychiatry 143, 993-997 (1986).
3. Morens, D. M., Grandinetti, A., Reed, D., White, L. R. & Ross, G. W. Neurology 45, 1041-1051 (1995).
4. Berry, M. D., Juono, A. V. & Paterson, I. A. Prog. Neurobiol. 42, 375-391 (1994).
5. Reiter, R. J FASEB J. 9, 526-533 (1995).
6. Fowler, J. S. et al. J. Neurochem. 51, 1524-1534 (1988)
7. Fowler, J S. et al J. nucl. Med. 36, 1255-1262 (1995).
8. Patlak, C. S., Blasberg, R. G. & Fenstermacher, J D. J. cereb. Blood Flow Metab. 3, 1-7 (1983).
9. Yamashita, K , Kobayashi, S., Yamaguchi, S., Kitani, M. & Tsunematsu, T. Gerontology 34, 199-204 (1988).
10. Wang, G.-J., Volkow, N. D., Wolf, A P., Brodie, J. D. & Hitzemann, R. J. J. nucl. Med. 35, 1457-1466 (1994).
11. Stapleton, J. M. et al. National Institute on Drug Abuse Res Monogr. Ser. Vol. 132, 106 (Department of Health and Human Services, Washington DC, 1993).
12. Riederer, P. & Youdim, M B H J. Neurochem. 46, 1359-1365 (1986).
13. Oreland., L , Fowler, C. J & Schalling, D. Life Sci. 29, 2511-2518 (1981)
14. Norman, T R., Chamberlain, K. G. & French, M. A. Psychiatry Res. 20, 199-205 (1987).
15. Carr, L A. & Rowell, P. P. Neuropharmacology 29, 311-314 (1990).
16. Pavlin, R & Sket, D. Farmacentski Vest. 44, 185-192 (1993).
17. Yu, P H & Boulton, A. A. Life Sci. 41, 675-682 (1987).
18. Carr, L. A. & Basham, J. K. Life Sci. 48, 1173-1177 (1991)
19. Fowler, J. S et al. Synapse 18, 86-93 (1994).
20. Boulton, A A , Yu, P. H. & Tipton, K. F. Lancet 1 114-115 (1988).
21. Yong, V W & Perry, T L J. neurol. Sci. 72, 265-272 (1986).
22. Tetrud, J W. & Langston, J. W. Science 245, 519-522 (1989).
23. Tanot, P. N., Cohen, R. M., Sunderland, T., Weingartner, H. & Murphey, D. L. Psychopharmacology 91, 489-495 (1987)
24. Knoll, J., Yen, T. T. & Miklya, I. Life Sci. 54, 1047-1057 (1994).
25. Dluzen, D E. & McDermott, J. L. J. neural Trans 85, 145-156 (1991)
26. Jackson, D M. & Westlind-Danielsson, A. in Pharmacology and Therapeutics Vol 64 (ed. Mitchelson, F.) 291-369 (Pergamon, UK, 1994).
27. Di Chiara, G. & Imperato, A. Proc. natn. Acad. Sci. U.S.A. 85, 5274-5278 (1988)
28. Paterson, I. A , Juono, A.V., Berry, M. D. & Zhu, M. Y J Pharmacol. exp. Ther. 258, 1019-1026 (1991)
29. Jossan, S. S., Sakurai, E. & Oreland, L. Biogenic Amines 4, 371-379 (1987).
30. Dougherty, E An Introduction to Morphological Image Processing (SPIE Optical Engineering Press, Bellingham, WA, 1992).
31. Berlin, I et al. Clin. Pharmac. Ther. 58, 444-452 (1995).